Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|March 27, 2014
Smartphones and tablets: Reshaping radiation oncologists' livesAlfonso Gomez-Iturriaga, Pedro Bilbao, Francisco Casquero, et al.Journal of Contemporary Brachytherapy|January 25, 2017
Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomyDavid Buchser, Alfonso Gomez-Iturriaga, J Ignacio Rodriguez Melcon, et al.Chinese Journal of Cancer|October 10, 2013
A prospective analysis of factors that influence weight loss in patients undergoing radiotherapyJon Cacicedo, Francisco Casquero, Lorea Martinez-Indart, et al.Cancer Treatment Reviews|September 3, 2013
The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approachJon Cacicedo, Arturo Navarro, Filippo Alongi, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2017
Health-related-quality-of-life and toxicity after single fraction 19 Gy high-dose-rate prostate brachytherapy: Phase II trialAlfonso Gomez-Iturriaga, Francisco Casquero, Jose Ignacio Pijoan, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2016
Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trialAlfonso Gomez-Iturriaga, Francisco Casquero, Arantza Urresola, et al.International Journal of Radiation Oncology, Biology, Physics|June 5, 2018
Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate CancerAlfonso Gomez-Iturriaga, Francisco Casquero, Jose Ignacio Pijoan, et al.Journal of Contemporary Brachytherapy|May 24, 2021
Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer controlEsther Mayrata, Jose Maria Espinosa, David Büchser, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2020
Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trialAlfonso Gomez-Iturriaga, David Buchser, Esther Mayrata, et al.Journal of Medical Imaging and Radiation Oncology|July 31, 2020
Pain response and quality of life assessment in patients with moderate/severe neuropathic pain due to bone metastasis undergoing treatment with palliative radiotherapy and tapentadol: A prospective multicentre pilot studyJon Cacicedo, Juan Pablo Ciria, Virginia Morillo, et al.Pageof 3